These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38176857)

  • 21. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study design and rationale of EXPLORER-CN: a phase III, randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy.
    Tian Z; Wang F; Jin W; Zhang Q; Zhou J; Yang P; Wang G; Hsu P; Sun J; Zhang S; Han Y
    BMJ Open; 2023 Jun; 13(6):e071473. PubMed ID: 37336533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH; Sajko MC; Rot U
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial.
    Khodaie F; Naser Moghadasi A; Kazemi AH; Zhao B
    Acupunct Med; 2023 Aug; 41(4):199-205. PubMed ID: 36722418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring and predicting the effect of remyelinating therapy in multiple sclerosis: a randomised controlled trial protocol (RESTORE).
    Hof S; van Rijn LJ; Uitdehaag BMJ; Nij Bijvank JA; Petzold A
    BMJ Open; 2024 Jan; 14(1):e076651. PubMed ID: 38296293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of
    Wu T; Li S; Li Z; Long W; Liu Q; Tang H; Huang X; Tang Y; Dong X; Ning Y; Tian S; Xu T; Xian SX; Liao H; Hong Y; Yang Z
    BMJ Open; 2023 May; 13(5):e055263. PubMed ID: 37164472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
    Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
    BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D for the management of multiple sclerosis.
    Jagannath VA; Filippini G; Di Pietrantonj C; Asokan GV; Robak EW; Whamond L; Robinson SA
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD008422. PubMed ID: 30246874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
    Metzger-Peter K; Kremer LD; Edan G; Loureiro De Sousa P; Lamy J; Bagnard D; Mensah-Nyagan AG; Tricard T; Mathey G; Debouverie M; Berger E; Kerbrat A; Meyer N; De Seze J; Collongues N
    Trials; 2020 Jun; 21(1):591. PubMed ID: 32600454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES).
    Riemenschneider M; Hvid LG; Ringgaard S; Nygaard MKE; Eskildsen SF; Petersen T; Stenager E; Dalgas U
    BMJ Open; 2021 Jan; 11(1):e043699. PubMed ID: 33436475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of multisession transcranial direct current stimulation as an augmentation to cognitive tasks in patients with neurocognitive disorders in Japan: a study protocol for a randomised controlled trial.
    Inagawa T; Yokoi Y; Yamada Y; Miyagawa N; Otsuka T; Yasuma N; Omachi Y; Tsukamoto T; Takano H; Sakata M; Maruo K; Matsui M; Nakagome K
    BMJ Open; 2020 Dec; 10(12):e037654. PubMed ID: 33361162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for fatigue in peripheral neuropathy.
    White CM; van Doorn PA; Garssen MP; Stockley RC
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008146. PubMed ID: 25519471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): study protocol for a randomised controlled trial.
    Brown S; Nixon J; Ransom M; Gilberts R; Dewhirst N; McGinnis E; Longo R; Game F; Bojke C; Chadwick P; Chandrasekar A; Chetter I; Collier H; Fernandez C; Homer-Vanniasinkam S; Jude E; Leigh R; Lomas R; Vowden P; Wason J; Sharples L; Russell D
    BMJ Open; 2020 Apr; 10(4):e035947. PubMed ID: 32312727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.